Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01824173 · ClinicalTrials.gov registry record · Phase 1
Muscle Protein Metabolism in Obesity
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 84
- Enrollment target
NCT01824173: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT01824173 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01824173, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 84 participants
- Enrollment target
Study Summary
Obesity is associated with reduced adenosine triphosphate (ATP) turnover in skeletal muscle, a condition that can impair muscle metabolism. The proposed research will discover mechanisms responsible for decreased content in mitochondrial proteins as well as in protein β-F1-ATPase, which is directly responsible for ATP assembly, in the muscle of obese individuals. This research will further examine the effectiveness of interventions, such as increased plasma amino acid availability and exercise, to increase the rate of production of mitochondrial proteins as well as that of β-F1-ATPase in the muscle of obese individuals. The findings will help to develop appropriate interventions to improve muscle ATP turnover and metabolism in obese people.
Interventions
- OTHER Aerobic exercise
- OTHER Increase in the levels of plasma amino acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2012-10 |
| Est. Completion | 2020-02-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01824173
The ClinicalTrials.gov registry entry for NCT01824173 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aerobic exercise is the first listed.
NCT01824173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01824173 about?
NCT01824173 is a clinical study titled "Muscle Protein Metabolism in Obesity". Obesity is associated with reduced adenosine triphosphate (ATP) turnover in skeletal muscle, a condition that can impair muscle metabolism. The proposed research will discover mechanisms responsible for decreased content in mitochondrial proteins as well as in protein β-F1-ATPase, which is directly ...
What is the current status of trial NCT01824173?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 84 participants. The study started on 2012-10. Estimated completion is 2020-02-07.
What interventions are being tested in trial NCT01824173?
The interventions under investigation include: Aerobic exercise (OTHER), Increase in the levels of plasma amino acids (OTHER).
Who is sponsoring clinical trial NCT01824173?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.